MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.
Publication
, Journal Article
Cahill, DP; Codd, PJ; Batchelor, TT; Curry, WT; Louis, DN
Published in: Clin Neurosurg
2008
Duke Scholars
Published In
Clin Neurosurg
ISSN
0069-4827
Publication Date
2008
Volume
55
Start / End Page
165 / 171
Location
United States
Related Subject Headings
- Temozolomide
- Radiotherapy, Adjuvant
- Neoplasm Recurrence, Local
- Middle Aged
- Humans
- Glioblastoma
- Gene Silencing
- Female
- Drug Resistance, Neoplasm
- Disease Progression
Citation
APA
Chicago
ICMJE
MLA
NLM
Cahill, D. P., Codd, P. J., Batchelor, T. T., Curry, W. T., & Louis, D. N. (2008). MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. Clin Neurosurg, 55, 165–171.
Cahill, Daniel P., Patrick J. Codd, Tracy T. Batchelor, William T. Curry, and David N. Louis. “MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.” Clin Neurosurg 55 (2008): 165–71.
Cahill DP, Codd PJ, Batchelor TT, Curry WT, Louis DN. MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. Clin Neurosurg. 2008;55:165–71.
Cahill, Daniel P., et al. “MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.” Clin Neurosurg, vol. 55, 2008, pp. 165–71.
Cahill DP, Codd PJ, Batchelor TT, Curry WT, Louis DN. MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. Clin Neurosurg. 2008;55:165–171.
Published In
Clin Neurosurg
ISSN
0069-4827
Publication Date
2008
Volume
55
Start / End Page
165 / 171
Location
United States
Related Subject Headings
- Temozolomide
- Radiotherapy, Adjuvant
- Neoplasm Recurrence, Local
- Middle Aged
- Humans
- Glioblastoma
- Gene Silencing
- Female
- Drug Resistance, Neoplasm
- Disease Progression